LianBio (LIAN) Competitors $0.42 0.00 (-0.89%) As of 07/14/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendFDA EventsInsider TradesSEC FilingsTrendsBuy This Stock LIAN vs. TLSA, PROK, PBYI, CYBN, LFVN, IMAB, VYGR, DERM, IPHA, and NVCTShould you be buying LianBio stock or one of its competitors? The main competitors of LianBio include Tiziana Life Sciences (TLSA), ProKidney (PROK), Puma Biotechnology (PBYI), Cybin (CYBN), Lifevantage (LFVN), I-Mab (IMAB), Voyager Therapeutics (VYGR), Journey Medical (DERM), Innate Pharma (IPHA), and Nuvectis Pharma (NVCT). These companies are all part of the "pharmaceutical products" industry. LianBio vs. Its Competitors Tiziana Life Sciences ProKidney Puma Biotechnology Cybin Lifevantage I-Mab Voyager Therapeutics Journey Medical Innate Pharma Nuvectis Pharma Tiziana Life Sciences (NASDAQ:TLSA) and LianBio (NASDAQ:LIAN) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations. Do institutionals & insiders believe in TLSA or LIAN? 74.8% of LianBio shares are held by institutional investors. 39.8% of Tiziana Life Sciences shares are held by company insiders. Comparatively, 7.6% of LianBio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is TLSA or LIAN more profitable? Tiziana Life Sciences' return on equity of 0.00% beat LianBio's return on equity.Company Net Margins Return on Equity Return on Assets Tiziana Life SciencesN/A N/A N/A LianBio N/A -33.17%-30.19% Does the media prefer TLSA or LIAN? In the previous week, Tiziana Life Sciences had 2 more articles in the media than LianBio. MarketBeat recorded 2 mentions for Tiziana Life Sciences and 0 mentions for LianBio. Tiziana Life Sciences' average media sentiment score of 0.63 beat LianBio's score of 0.00 indicating that Tiziana Life Sciences is being referred to more favorably in the media. Company Overall Sentiment Tiziana Life Sciences Positive LianBio Neutral Which has more risk & volatility, TLSA or LIAN? Tiziana Life Sciences has a beta of -0.05, indicating that its share price is 105% less volatile than the S&P 500. Comparatively, LianBio has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500. Which has better earnings & valuation, TLSA or LIAN? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTiziana Life SciencesN/AN/A-$11.86MN/AN/ALianBioN/AN/A-$110.29M-$0.81-0.52 SummaryTiziana Life Sciences beats LianBio on 6 of the 8 factors compared between the two stocks. Get LianBio News Delivered to You Automatically Sign up to receive the latest news and ratings for LIAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LIAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIAN vs. The Competition Export to ExcelMetricLianBioBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$45.68M$130.80M$5.62B$9.29BDividend YieldN/A3.74%4.25%4.03%P/E Ratio-0.523.6028.5719.58Price / SalesN/A4,216.21423.3293.40Price / CashN/A13.1936.0257.93Price / Book0.1641.838.135.54Net Income-$110.29M-$92.15M$3.24B$257.73M7 Day Performance0.65%0.65%0.16%-0.08%1 Month Performance11.40%5.08%5.95%8.09%1 Year Performance41.77%160.37%26.09%13.02% LianBio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIANLianBioN/A$0.42-0.9%N/A+42.2%$45.68MN/A-0.52110TLSATiziana Life Sciences1.3337 of 5 stars$1.49-2.6%N/A+82.6%$178.78MN/A0.008PROKProKidney3.5224 of 5 stars$3.73+515.0%$3.50-6.2%+41.0%$177.52M$80K-6.223Trending NewsAnalyst ForecastGap UpHigh Trading VolumePBYIPuma Biotechnology4.1989 of 5 stars$3.59+1.4%$7.00+95.0%-5.5%$175.69M$230.50M4.66200Gap UpCYBNCybin2.47 of 5 stars$7.63-3.0%$85.00+1,014.0%N/A$175.67MN/A-1.7450LFVNLifevantage4.2716 of 5 stars$14.12+3.9%$30.50+116.0%+102.6%$171.07M$200.16M20.46260News CoveragePositive NewsIMABI-Mab2.8503 of 5 stars$2.20+5.3%$6.00+172.7%+28.8%$170.67M$3.89M0.00380Gap DownVYGRVoyager Therapeutics3.8932 of 5 stars$3.18+4.6%$13.39+321.1%-65.6%$168.22M$80M-2.18100DERMJourney Medical2.3979 of 5 stars$6.92-2.7%$9.50+37.3%+19.9%$165.63M$56.13M0.0090Positive NewsIPHAInnate Pharma2.6155 of 5 stars$1.75-2.2%$11.00+528.6%-16.5%$165M$21.77M0.00220Positive NewsNVCTNuvectis Pharma3.3036 of 5 stars$7.58-3.4%$17.00+124.3%+24.5%$164.01MN/A-6.718Positive News Related Companies and Tools Related Companies TLSA Alternatives PROK Alternatives PBYI Alternatives CYBN Alternatives LFVN Alternatives IMAB Alternatives VYGR Alternatives DERM Alternatives IPHA Alternatives NVCT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LIAN) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LianBio Please log in to your account or sign up in order to add this asset to your watchlist. Share LianBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
